行情

CTSO

CTSO

Cytosorbents
NASDAQ

实时行情|Nasdaq Last Sale

5.25
-0.39
-6.91%
已收盘, 16:00 02/27 EST
开盘
5.80
昨收
5.64
最高
6.17
最低
5.24
成交量
56.57万
成交额
--
52周最高
8.48
52周最低
3.490
市值
1.70亿
市盈率(TTM)
-8.1257
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测CTSO价格均价为11.90,最高价位15.00,最低价为8.00。

EPS

CTSO 新闻

更多
  • 周四美油收跌3.4%创一年新低 布油收跌2.3%
  • 新浪美股 · 53分钟前
  • 黄金期货周四小幅收跌 已连跌3日
  • 新浪美股 · 1小时前
  • 加拿大多伦多股市宣布“技术性停盘”
  • 央视 · 1小时前
  • 美国股市的恐慌指标突破上次熊市临近时的水平
  • 新浪财经 · 1小时前

所属板块

先进医疗设备和技术
-3.12%
医疗设备和用品
-2.75%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

CTSO 简况

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads that remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The Company's CytoSorb is an extracorporeal cytokine filter and is designed to reduce the cytokine storm that causes inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury and pancreatitis. In addition, CytoSorb is used in other inflammatory conditions, such as cardiac surgery and autoimmune disease flares and cancer cachexia. It also has other products under development based upon its blood purification technology, including HemoDefend, ContrastSorb, DrugSorb, BetaSorb and others.
展开

微牛提供Cytosorbents Corp(NASDAQ-CTSO)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的CTSO股票新闻,以帮助您做出投资决策。